The field of ophthalmology is ever-evolving with advancements in treatments and therapeutics, yet there are still many unmet needs in the posterior segment particularly with IRDs and dry AMD. In this webinar presented on April 21, 2020, Keith Lane, Executive Director and Therapeutic Area Head for Posterior Segment and Divya Narayanan, Senior Clinical Scientist-Retina, discuss how Ora is solving for these unmet needs by developing novel, sensitive visual function endpoints to help overcome development hurdles and evaluate efficacy for new therapies.
